Ferrous asparto glycinate

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Logo pink
Are you a
new drug developer?
Contact us to learn more about our customized products and solutions.
Name
Ferrous asparto glycinate
Accession Number
DB11169
Type
Small Molecule
Groups
Approved
Description

Ferrous asparto glycinate is an iron-amino acid chelate. It is available as a dietary supplement used in the treatment of iron deficiency and iron deficiency anemia.

Synonyms
Not Available
Active Moieties
NameKindUNIICASInChI Key
IronunknownE1UOL152H77439-89-6XEEYBQQBJWHFJM-UHFFFAOYSA-N
Ferrous cationionicGW89581OWR15438-31-0CWYNVVGOOAEACU-UHFFFAOYSA-N
Unapproved/Other Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing End
Cavan OneFerrous asparto glycinate (7 mg/1) + Alpha-Linolenic Acid (30 mg/1) + Calcium (150 mg/1) + Calcium ascorbate dihydrate (25 mg/1) + Cholecalciferol (170 [iU]/1) + DL-alpha tocopheryl acetate (30 [iU]/1) + Doconexent (260 mg/1) + Folic Acid (1 mg/1) + Icosapent (40 mg/1) + Iron (20 mg/1) + Linoleic acid (30 mg/1) + Pyridoxine hydrochloride (25 mg/1)Capsule, gelatin coatedOralSeton Pharmaceuticals2009-10-302011-11-27Us
ChromagenFerrous asparto glycinate (25 mg/1) + Ascorbic acid (60 mg/1) + Cyanocobalamin (10 ug/1) + Ferrous fumarate (50 mg/1) + Folic Acid (250 ug/1) + Gastric intrinsic factor (100 mg/1) + Levomefolic acid (750 ug/1) + Zinc (12 mg/1)CapsuleOralAvion Pharmaceuticals, Llc2017-01-23Not applicableUs
FeRiva FAFerrous asparto glycinate (36.7 mg/1) + Ascorbic acid (175 mg/1) + Biotin (300 ug/1) + Cupric oxide (1.5 mg/1) + Cyanocobalamin (12 ug/1) + Docusate sodium (50 mg/1) + Ferrous bisglycinate (36.7 mg/1) + Ferrous fumarate (36.7 mg/1) + Folic Acid (1 mg/1)Capsule, gelatin coatedOralAvion Pharmaceuticals, Llc2015-01-20Not applicableUs
Folcaps Omega-3Ferrous asparto glycinate (7 mg/1) + Alpha-Linolenic Acid (30 mg/1) + Calcium (150 mg/1) + Calcium ascorbate dihydrate (24 mg/1) + Calcium threonate (1 mg/1) + Cholecalciferol (170 [iU]/1) + Doconexent (260 mg/1) + Folic Acid (1 mg/1) + Icosapent (40 mg/1) + Iron (20 mg/1) + Pyridoxine hydrochloride (25 mg/1) + alpha-Tocopherol acetate (30 [iU]/1)Capsule, gelatin coatedOralMayne Pharma2011-01-032016-12-31Us
Integra FFerrous asparto glycinate (135.9 mg/1) + Ascorbic acid (40 mg/1) + Ferrous fumarate (191.2 mg/1) + Folic Acid (1 mg/1) + Niacin (3 mg/1)CapsuleOralUs Pharmaceutical Corporation2009-04-27Not applicableUs
Integra PlusFerrous asparto glycinate (135.9 mg/1) + Ascorbic acid (210 mg/1) + Biotin (300 ug/1) + Ferrous fumarate (191.2 mg/1) + Folic Acid (1 mg/1) + Niacin (20 mg/1) + Calcium pantothenate (7 mg/1) + Pyridoxine hydrochloride (25 mg/1) + Riboflavin (5 mg/1) + Thiamine mononitrate (5 mg/1)CapsuleOralUs Pharmaceutical Corporation2009-04-27Not applicableUs
NiferexFerrous asparto glycinate (50 mg/1) + Ascorbic acid (60 mg/1) + Cyanocobalamin (25 ug/1) + Folic Acid (250 ug/1) + Gastric intrinsic factor (100 mg/1) + Iron Dextran (100 mg/1) + Levomefolic acid (750 ug/1) + Succinic acid (50 mg/1) + Zinc (15 mg/1)TabletOralAvion Pharmaceuticals, Llc2017-01-23Not applicableUs
Paire OB Plus DHAFerrous asparto glycinate (6 mg/1) + Biotin (30 ug/1) + Cupric sulfate pentahydrate (0.8 mg/1) + Cyanocobalamin (12 ug/1) + D-alpha-Tocopherol acetate (10 [iU]/1) + Doconexent (200 mg/1) + Folic Acid (1 mg/1) + Iron (22 mg/1) + Nicotinamide (17 mg/1) + Calcium pantothenate (10 mg/1) + Potassium Iodide (175 ug/1) + Pyridoxine hydrochloride (50 mg/1) + Riboflavin (1.6 mg/1) + Sodium selenate (65 ug/1) + Thiamine mononitrate (1.5 mg/1) + Vitamin D (400 [iU]/1) + Zinc oxide (15 mg/1)KitCentrix Pharmaceutical2010-10-132015-07-31Us
Prenate DHAFerrous asparto glycinate (18 mg/1) + Ascorbic acid (90 mg/1) + Cholecalciferol (400 [iU]/1) + Cyanocobalamin (25 ug/1) + DL-alpha-Tocopherol (40 [iU]/1) + Doconexent (300 mg/1) + Folic Acid (1 mg/1) + Calcium formate (155 mg/1) + Magnesium oxide (50 mg/1) + Pyridoxine hydrochloride (26 mg/1)Capsule, gelatin coatedOralAvion Pharmaceuticals, Llc2014-06-05Not applicableUs
Prenate EliteFerrous asparto glycinate (20 mg/1) + 5-methyltetrahydrofolic acid (600 ug/1) + Ascorbic acid (75 mg/1) + Beta carotene (2600 [iU]/1) + Biotin (330 ug/1) + Cholecalciferol (600 [iU]/1) + Cupric oxide (1.5 mg/1) + Cyanocobalamin (13 ug/1) + DL-alpha tocopheryl acetate (40 [iU]/1) + Folic Acid (400 ug/1) + Calcium formate (155 mg/1) + Magnesium oxide (25 mg/1) + Nicotinamide (21 mg/1) + Potassium Iodide (150 ug/1) + Pyridoxine hydrochloride (21 mg/1) + Riboflavin (3.5 mg/1) + Thiamine mononitrate (3 mg/1) + Zinc oxide (15 mg/1)Tablet, coatedOralAvion Pharmaceuticals, Llc2014-06-05Not applicableUs
Categories
Not Available
UNII
H7426RGB3L
CAS number
Not Available
Weight
Not Available
Chemical Formula
Not Available
InChI Key
Not Available
InChI
Not Available
IUPAC Name
Not Available
SMILES
Not Available

Pharmacology

Indication
Not Available
Pharmacodynamics
Not Available
Mechanism of action
Not Available
Additional Data Available
Adverse Effects

Comprehensive structured data on known drug adverse effects with statistical prevalence. MedDRA and ICD10 ids are provided for adverse effect conditions and symptoms.

Learn more
Additional Data Available
Contraindications

Structured data covering drug contraindications. Each contraindication describes a scenario in which the drug is not to be used. Includes restrictions on co-administration, contraindicated populations, and more.

Learn more
Additional Data Available
Blackbox Warnings

Structured data representing warnings from the black box section of drug labels. These warnings cover important and dangerous risks, contraindications, or adverse effects.

Learn more
Absorption
Not Available
Volume of distribution
Not Available
Protein binding
Not Available
Metabolism
Not Available
Route of elimination
Not Available
Half life
Not Available
Clearance
Not Available
Toxicity
Not Available
Affected organisms
Not Available
Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
Not Available
Food Interactions
Not Available

References

General References
Not Available
External Links
PubChem Substance
347911142

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount
1, 2RecruitingTreatmentPostpartum Anemia1
4TerminatedTreatmentAnemias1

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage forms
FormRouteStrength
Capsule, gelatin coatedOral
CapsuleOral
TabletOral
Capsule, liquid filledOral
Tablet, coatedOral
Tablet, film coatedOral
Kit
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available
Predicted Properties
Not Available
Predicted ADMET features
Not Available

Spectra

Mass Spec (NIST)
Not Available
Spectra
Not Available

Taxonomy

Classification
Not classified

Drug created on December 03, 2015 09:51 / Updated on June 04, 2019 07:17